Tech Company Financing Transactions

Mitokyne Funding Round

Mitokyne secured a $45 million Series A funding round on 10/21/2013. Backers included Astellas Venture Capital, Longwood Founders Fund and MPM Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

200 Clarendon St. 54th Floor
Boston, MA 02116
USA

Phone

(617) 425-9200

Website

Email Address

Not Recorded

Overview

Mitokyne is a biotech company focused on mitochondria-related drug discovery and development. The company is utilizing its innovative screening platform to identify and develop novel drugs that improve mitochondria function and provide treatments for genetic, metabolic and neurodegenerative disorders as well as diseases and conditions of aging.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Kazumi Shiosaki

        

Browse more venture capital transactions:

Prev: 10/21/2013: Mach 1 Development venture capital transaction
Next: 10/21/2013: BountyJobs venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site come from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary